Spectrum Pharmaceuticals reaches agreement with FDA on SPA for of SPI-2012 trial Dec. 21, 2015 No Comments
Arch Therapeutics reports preclinical data for hemostatic; cleared to start clinical trial in Europe Dec. 17, 2015 No Comments
Akebia Therapeutics and Mitsubishi Tanabe Pharma sign agreement for vadadustat in Asia Dec. 15, 2015 No Comments
Achillion's oral, small-molecule reversible factor D inhibitors for PNH and aHUS Dec. 11, 2015 No Comments
Novel optimized human FVIII vector SPK-8005 demonstrates therapeutic utility in hemophilia Dec. 11, 2015 No Comments
Luspatercept receives FDA fast track designation for anemia in lower-risk MDS Dec. 9, 2015 No Comments